Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice

BACKGROUND: There is scant data from India on efficacy and safety of palbociclib and ribociclib in routine clinical practice. METHODS: This retrospective, observational, single institution study included patients with estrogen and/or progesterone receptor positive and human epidermal growth factor r...

Descripción completa

Detalles Bibliográficos
Autores principales: Rath, Sushmita, Elamarthi, Prahalad, Parab, Pallavi, Gulia, Seema, Nandhana, Ravindra, Mokal, Smruti, Kembhavi, Yogesh, Perumal, Prema, Bajpai, Jyoti, Ghosh, Jaya, Gupta, Sudeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297817/
https://www.ncbi.nlm.nih.gov/pubmed/34292933
http://dx.doi.org/10.1371/journal.pone.0253722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297817/
https://www.ncbi.nlm.nih.gov/pubmed/34292933
http://dx.doi.org/10.1371/journal.pone.0253722

Ejemplares similares